|
Market Closed -
OTC Markets
15:42:53 15/07/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | - |
| Market Cap | 6.24M 4.41M 3.87M 3.66M 3.33M 423M 6.28M 43.76M 16.95M 216M 16.57M 16.21M 694M | P/E 2022 |
-2.09x | P/E 2023 | -0.45x |
|---|---|---|---|---|---|
| Enterprise Value | 64.5M 45.62M 40.03M 37.81M 34.45M 4.37B 64.96M 452M 175M 2.23B 171M 168M 7.18B | EV / Sales 2022 |
3.37x | EV / Sales 2023 | 1.35x |
| Free-Float |
52.66% | Yield 2022 * |
-
| Yield 2023 | - |
| Current year | 0 |  | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0.25 |
| 5 years | 0 | | 0.84 |
| 10 years | 0 | | 1.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Steven Saviuk
CEO | Chief Executive Officer | 67 | 26/03/2003 |
Pascal Tougas
DFI | Director of Finance/CFO | - | 19/11/2023 |
Frédéric Dumais
IRC | Investor Relations Contact | - | 31/05/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Steven Saviuk
CHM | Chairman | 67 | 05/08/2024 |
Richard MacKay
CHM | Chairman | 91 | 24/07/2018 |
Marc Léger
BRD | Director/Board Member | 67 | 26/04/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/11/24 | Other | Investor Relations Manager | 0 | 0% | ||
| 11/11/24 | Other | Investor Relations Manager | 0 | 0% | ||
| 11/11/24 | Other | Investor Relations Manager | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 98 | |
| +0.13% | +2.65% | +65.61% | +114.28% | 1,055B | |
| +0.20% | +0.46% | +52.60% | +69.24% | 654B | |
| -0.29% | +0.14% | +20.96% | +70.93% | 467B | |
| -0.85% | +0.98% | +41.29% | +44.38% | 348B | |
| +0.71% | +4.08% | +22.24% | +29.51% | 275B | |
| +1.23% | +0.42% | +14.57% | +12.13% | 258B | |
| +2.11% | +7.51% | +52.89% | +55.37% | 224B | |
| +0.83% | +0.55% | +35.99% | +101.70% | 187B | |
| 0.00% | -10.14% | -29.94% | -60.30% | 171B | |
| Average | +0.32% | +0.67% | +30.69% | +48.58% | 363.84B | |
| Weighted average by Cap. | +0.02% | +1.32% | +41.54% | +67.83% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 27.74M 19.62M 17.22M 16.26M 14.82M 1.88B 27.94M 195M 75.38M 961M 73.68M 72.09M 3.09B | 53.91M 38.13M 33.46M 31.6M 28.8M 3.65B 54.29M 378M 146M 1.87B 143M 140M 6B |
| Net income | -25.75M -18.21M -15.98M -15.09M -13.75M -1.75B -25.93M -181M -69.95M -892M -68.37M -66.89M -2.87B | -27.81M -19.67M -17.26M -16.3M -14.86M -1.89B -28.01M -195M -75.55M -963M -73.85M -72.25M -3.1B |
| Net Debt | 38.94M 27.54M 24.17M 22.83M 20.8M 2.64B 39.22M 273M 106M 1.35B 103M 101M 4.33B | 58.26M 41.21M 36.16M 34.15M 31.12M 3.95B 58.67M 409M 158M 2.02B 155M 151M 6.48B |
Employees
70
Sector
Pharmaceuticals
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VPHIF Stock
Select your edition
All financial news and data tailored to specific country editions
